With the aim of promoting innovative cardiovascular research, The Institute for Cardiogenetics are collaborating with VIAgenomics to translate years of knowledge into pioneering treatment.
In early 2018, VIAgenomics and The Institute for Cardiogenetics were thrilled to announce funding introduced by The British Heart Foundation (BHF) and the German Centre for Cardiovascular Research (DZHK e.V.) to promote international cooperation between cardiovascular researchers in Great Britain and Germany.
Receiving €2.4 million, the collaboration has the aim to promote innovative cardiovascular research with the potential for improved clinical diagnosis, prevention or treatment. This eBook shines a light on the exciting collaboration.
Did you know that The Institute for Cardiogenetics are Partners with Health Europa? Read more about the revolutionary discoveries our incredible Partners are conducting regarding the world of cardiovascular genomics research.
Collaborating to take cardiovascular research to the next level
The multidisciplinary team has been assembled with a history of impactful collaborations and a highly successful track record. The alliance includes clinicians, geneticists, bioinformaticians, and scientists with complementary expertise.
This eBook highlights the collaboration of the research team, focusing on:
- How genes affect the risk for heart disease; and
- The combining of innovative computer-assisted and laboratory-experimental methods to identify novel causal mechanisms with translational potential.
Curious to know more about The Institute for Cardiogenetics? Intrigued to explore VIAgenomics further? Click below to learn more:
What do you know about the DZHK e.V. and The British Heart Foundation?
The DZHK focuses on translating new approaches in cardiovascular research into clinical practice as rapidly as possible in order to improve diagnosis, prevention and treatment of cardiovascular diseases. This mission of funding the collaboration of The Institute for Cardiogenetics and VIAgenomics is of utmost clinical and health economic importance because in the future, the incidence of cardiovascular disease will increase further as a result of the rising incidence of metabolic disorders (such as obesity, diabetes) and due to demographic change.
The British Heart Foundation (BHF) is a charity organisation in the UK, and funds research to beat heartbreak from heart and circulatory diseases and their risk factors. It is a major funder and authority in cardiovascular research, education, and care, and relies predominantly on voluntary donations to meet its aims.